“Inhibiting DGKi seems to reverse the effects of cystic fibrosis”
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Regensburg University, both in Germany, and the University of Lisboa, in Portugal, have discovered a promising potential drug target for cystic fibrosis. Their work, published online today in Cell, also uncovers a large set of genes not previously linked to the disease, demonstrating how a new screening technique can help identify new drug targets.
Cystic fibrosis is a hereditary disease caused by mutations in a single gene called CFTR. These mutations cause problems in various organs, most notably making the lining of the lungs secrete unusually thick mucus. This leads to recurrent life-threatening lung infections, which make it increasingly hard for patients to breathe. The disease is estimated to affect 1 in every 2500-6000 newborns in Europe.
In patients with cystic fibrosis, the mutations to CFTR render it unable to carry out its normal tasks. Among other things, this means CFTR loses the ability to control a protein called the epithelial sodium channel (ENaC). Released from CFTR’s control, ENaC becomes hyperactive, cells in the lungs absorb too much sodium and – as water follows the sodium – the mucus in patients’ airways becomes thicker and the lining of the lungs becomes dehydrated. The only drug currently available that directly counteracts a cystic fibrosis-related mutation only works on the three percent of patients that carry one specific mutation out of the almost 2000 CFTR mutations scientists have found so far.
Thus, if you were looking for a more efficient way to fight cystic fibrosis, finding a therapy that would act upon ENaC instead of trying to correct that multitude of CFTR mutations would seem like a good option. But unfortunately, the drugs that inhibit ENaC, mostly developed to treat hypertension, don’t transfer well to cystic fibrosis, where their effects don’t last very long. So scientists at EMBL, Regensburg University and University of Lisboa set out to find alternatives.
“In our screen, we attempted to mimic a drug treatment,” says Rainer Pepperkok, whose team at EMBL developed the technique, “we’d knock down a gene and see if ENaC became inhibited.”
Starting with a list of around 7000 genes, the scientists systematically silenced each one, using a combination of genetics and automated microscopy, and analysed how this affected ENaC. They found over 700 genes which, when inhibited, brought down ENaC activity, including a number of genes no-one knew were involved in the process. Among their findings was a gene called DGKi. When they tested chemicals that inhibit DGKi in lung cells from cystic fibrosis patients, the scientists discovered that it appears to be a very promising drug target.
“Inhibiting DGKi seems to reverse the effects of cystic fibrosis, but not block ENaC completely,” says Margarida Amaral from the University of Lisboa, “indeed, inhibiting DGKi reduces ENaC activity enough for cells to go back to normal, but not so much that they cause other problems, like pulmonary oedema.”
The Latest on: Cystic fibrosis
Bribie Island teenager with cystic fibrosis is battling for a national modelling title - and her life
on April 22, 2018 at 12:00 pm
MANY models are looking to become rich and famous, but not Megan Roe. The 18 year old wants to raise awareness of a condition which she says “will kill” her. Ms Roe, from Bribie Island and has cystic fibrosis, has won through five rounds to reach the ... […]
Legoland, Disney World a wish fulfilled for 7-year-old with cystic fibrosis
on April 21, 2018 at 3:03 pm
Family and friends of Quinton Bates gathered at Pizza Hut on Friday evening to surprise him with a trip of a lifetime. As dad Corey Bates drove Quinton and his little brother, Xander, around waiting for the OK to bring them to the restaurant, mom Ashley ... […]
Va. Beach hosting Great Strides walk to help those living with cystic fibrosis
on April 20, 2018 at 9:31 pm
VIRGINIA BEACH, Va. (WAVY) -- You've heard there is strength in numbers, and while that may be true, a group of people coming together for a cause in Virginia Beach must be sure to keep their distance from one another. Saturday morning is the Great Strides ... […]
My friend’s diagnosis of cystic fibrosis has powerfully influenced her life—and mine.
on April 20, 2018 at 6:20 am
In a widely circulated essay in New York magazine, the writer Jen Gann describes her experience of learning that her newborn son, Dudley, has cystic fibrosis. Had she known of the diagnosis during pregnancy, she writes, “I would have had an abortion.&rdquo […]
Cystic Fibrosis Bocce Ball Fundraiser
on April 20, 2018 at 3:16 am
Hundreds will gather to play bocce ball for a great cause at the 12th annual Joey O Bocce Classic in honor of Cary resident Joe O’Connell who lost his fight with Cystic Fibrosis (CF) at the age of 32 in November 2009. The annual fundraiser, held by ... […]
Cystic Fibrosis 2018 Pipeline Highlights - ResearchAndMarkets.com
on April 20, 2018 at 2:32 am
DUBLIN--(BUSINESS WIRE)--The "Cystic Fibrosis Pipeline Highlights - 2018" report has been added to ResearchAndMarkets.com's offering. Cystic Fibrosis Pipeline Highlights - 2018, provides the most up-to-date information on key pipeline products in the ... […]
Global Cystic Fibrosis Therapeutics Market Overview 2017-2026: Teva Pharmaceutical Industries Ltd
on April 19, 2018 at 11:09 pm
Apr 20, 2018 (marketresearch.biz via COMTEX) -- The report on the global Cystic Fibrosis Therapeutics market is an insightful reference data for established players as well as new entrants in the Global Cystic Fibrosis Therapeutics market. The data shown ... […]
BRIEF-Proteostasis Receives Endorsement From Cystic Fibrosis Foundation For Study Of PTI-428 In CF Subjects On Background Symdeko Therapy
on April 17, 2018 at 9:08 am
April 17 (Reuters) - Proteostasis Therapeutics Inc: * PROTEOSTASIS RECEIVES ENDORSEMENT FROM THE CYSTIC FIBROSIS FOUNDATION’S THERAPEUTIC DEVELOPMENT NETWORK FOR THE STUDY OF THE COMPANY’S AMPLIFIER, PTI-428, IN CF SUBJECTS ON BACKGROUND SYMDEKO ... […]
Health Beat: A family's fight against cystic fibrosis
on April 13, 2018 at 12:13 pm
RALEIGH, N.C. - Imagine losing nearly all of your siblings to cystic fibrosis, a genetic condition that makes it difficult to breathe. There are some treatments, but so far, no cure. There's one woman who is working to turn her personal tragedy into triumph. […]
Global Cystic Fibrosis Therapeutics Market Opportunities 2018: Merck & Co , AstraZeneca Plc, Novartis AG, Alcresta Therapeutics
on April 9, 2018 at 11:34 pm
Apr 10, 2018 (marketresearch.biz via COMTEX) -- Global Cystic Fibrosis Therapeutics Market 2018 Market Size, Share, Global Trends, Price, Cystic Fibrosis Therapeutics Research Report, Segmentation and Forecast 2017-2026. The report on Global Cystic ... […]
via Google News and Bing News